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Case presentations
Patient 1. A 41-year-old man with chronic schizophrenia went to a
local hospital stating that he had attempted suicide by drinking lamp oil.
At the time of admission, he appeared intoxicated and quickly became
unresponsive and severely acidemic. Crystals resembling calcium oxa-
late monohydrate were noted in the urine. He was treated with an
alcohol infusion for suspected ethylene glycol intoxication and was
transferred to Denver General Hospital. The systolic blood pressure
was palpable at 80 mm Hg; pulse, 140 beats/mm; respirations, 24/mm;
temperature, 35°C. The patient was comatose and no deep-tendon
reflexes could be elicited. Initial laboratory data (Table I) included:
sodium, 146 mEq/liter; potassium, 3.1 mEq/liter; chloride, 100 mEq/
liter; bicarbonate, <10 mEq/liter; BUN, 13 mg/dl; creatinine, 2.4 mg/dl;
calcium, 8.6 mg/dl; phosphorus, 2.4 mg/dl; uric acid, 9.8 mgldl; glucose,
234 mg/dl; ethylene glycol, 86 mg/dl; measured serum osmolality, 353
mOsm/kg; and a calculated serum osmolality of 332 mOsm/kg.
The patient was treated initially with intravenous normal saline,
sodium bicarbonate (132 mEq), ethanol, thiamine, pyridoxine, and
pressor drugs; hemodialysis also was begun. His subsequent course
was complicated by acute renal failure requiring multiple dialyses. The
patient recovered complete neurologic function and had partial return
of renal function over one month. The serum creatinine fell to 2.1 mg/dl,
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and he was returned to the initial hospital for further care and
placement.
Patient 2. A 48-year-old male was admitted to Denver General
Hospital for severe alkalemia. He had a history of chronic alcohol
abuse. One week prior to admission he began drinking heavily. Three
days prior to admission he began to experience nausea and vomiting.
On the morning of admission severe spasms in his arms and legs caused
him to summon an ambulance. He denied ingestion of salicylates, other
medication, methanol, antifreeze, or "bootleg" liquor. He denied
seizures. The blood pressure was 130/80 mm Hg; pulse, 100 beats/mm;
respirations, 20/mm; and temperature, 38°C rectally. The patient was
alert and oriented but was experiencing spontaneous carpopedal spasm.
Initial laboratory data (Table 1) included: serum sodium, 141 mEq/liter;
potassium, 3.3 mEq/liter; chloride, 74 mEq/liter; bicarbonate, 32 mEq/
liter; and anion gap, 35 mEq/liter. The BUN was 37 mg/dl; creatinine,
2.5 mg/dl; calcium, 10.3 mg/dl; phosphorus, 2.6 mg/dl; uric acid, 12.8
mg/dl; a trace of ethanol; and a negative toxin screen for salicylates and
methanol. A serum screen for organic acids using gas chromatography
and mass spectroscopy revealed a peak for lactate as well as small
peaks for /3-OH butyrate, n-OH butyrate, cs-ketobutyrate, and two
unidentified substances.
The patient was treated with normal saline, potassium chloride,
magnesium sulfate, and thiamine. After 48 hours, acid-base status was
normal, the serum creatinine was 1.1 mg/dl, and the serum uric acid
measured 3.6 mg/dl.
Patient 3. A 34-year-old male developed low back pain 13 months
before admission. The back pain increased in severity and he experi-
enced a 10-pound weight loss. Multiple myeloma was diagnosed 9
months before admission. Chemotherapy with cyclophosphamide, yin-
cristine, melphalan, and prednisone was initiated. He was admitted to
Denver General Hospital for evaluation for further chemotherapy.
Laboratory data included: hemoglobin, 10.3 g/dl; sodium, 137 mEq/
liter; potassium, 3.9 mEq/liter; chloride, 105 mEq/liter; and bicarbon-
ate, 27 mEq/liter. The anion was gap 5 mEq/liter. Serum protein
electrophoresis revealed a monoclonal spike in the gamma region;
quantitative analysis revealed 5.1 g/dl of IgG kappa protein. The bone
marrow contained 73% plasma cells.
Discussion
DR. PATRICIA A. GABOW (Director, Medical Services, Den-
ver General Hospital, Denver, Colorado): The anion gap is a
concept based on the electrically neutral state of serum. It is not
a single laboratory measurement, and in different clinical condi-
tions it estimates different substances. Nonetheless, an assess-
ment of the magnitude of the gap has remarkable clinical utility.
The interpretation of an abnormal anion gap critically depends
on the clinical setting in which the deviation is encountered. To
clarify the complex concept of the anion gap, I will consider
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Table 1. Serum values
Anion Lac- Pyru- /3-OH Aceto- Cit-
Na K Cl HC03 gap Arte- PaCO2 Pa02 tate vate butyrate acetate rate
mEqi mEq/ mEqi mEqi mEqi rial mm mm mEqi mEqi mEqi mEqi mEqi
liter liter liter liter liter pH Hg Hg liter liter liter liter liter
Patient 1
Outside
hospital 131 3.6 100 <10 — 6.87 13 — — — — — —
On trans-
fer 146 3.1 100 4 42 7.17 16 153 8.6 0.21 0.069 0.103 0.379
At dis-
charge 139 4.5 108 20 11 — — — — —
— — —
Patient 2
Emergency
room 141 3.3 74 32 35 — — — — — — — —
On ad-
mission 135 3.3 76 29 30 7.76 20 70 6.59 0.48 0.80 0.31 —
2 hours
later 133 2.4 78 35 20 — — — — — — — —
At dis-
charge 140 4.4 103 25 12 — — — — — — — —
a Value obtained while patient was breathing supplemental oxygen.
Cations I Anions
Fig. 1. The ionic anatomy of serum. The charge contribution of the
serum cations equals that of the serum anions. (Reprinted by permis-
sion; from Ref. 1.)
first the chemistry that underlies the definition of the anion gap,
then the clinical disorders in which the anion gap is increased,
Table 2. Conversion of laboratory values for serum constituents to
mEq/litera
Ion
Units of concentration
'reported
Formula for conversion
to mEq/liter
Ca mg/dl x [10 ÷ 401 X 2Mg mg/dI x [10 ÷ 241 X 2
P04 (mgP) mg/dl x [10 ÷ 31] X 1.8
SO4 (mmol) mmol/liter X 2
a Conversion from milligrams per deciliter to mEq/liter is performed
by multiplying by 10 to convert to milligrams per liter, dividing by the
molecular weight, and finally multiplying by the valency.
and finally, I will examine the disorders associated with a
decreased anion gap.
Chemistry and definition
The concept of the anion gap arose from the "Gamblegram"
described in 1939 [1]. The Gamblegram, illustrated in Figure 1,
is a graphic representation of the law of electroneutrality as
applied to the charged constituents of serum. This law dictates
that the number of net positive charges contributed by serum
cations must equal the number of net negative charges contrib-
uted by serum anions.
Figure 1 illustrates the charge balance: sodium [Nat] +
potassium [K] + calcium {CaiJ + magnesium [MgiI =
bicarbonate [HCO3TJ + chloride [C11 + phosphate [P04] +
sulfate [SO4] + protein [Pr] + organic acid anions OA]. (I
should note that the phosphate and protein have multiple
charges). The units used are milliequivalents per liter because
the equation deals with the concentrations of charges (Table 2).
Assigning numerical values for the charges of these serum
constituents is accomplished easily for sodium, potassium,
bicarbonate, and chloride, but with more difficulty for many
other serum constituents. Although calcium and magnesium are
measured with relative ease, it is important to understand why
the total concentration of serum calcium and magnesium rather
than just the ionized fraction is used in the calculation of the
contribution of calcium to the so-called "unmeasured cations."
160
150
140
130
120
110
100
90
80
E
70
60
50
40
30
20
10
0
- HCO3' 27
— CI' 103
2
—sO4,, 1
Org. ac. 6
—Protein 16
142 Na -
5K —
5 Ca" -
3 Mg" —
474 Nephrology Forum
The rationale for this is straightforward: the calcium bound to
protein (for example, albumin, which is a polyanion) or corn-
plexed with bicarbonate, phosphate, sulfate, lactate, or citrate,
"covers" an equivalent number of negative charges on these
anions, that is, it is balanced electrically by those negative
charges. Thus, like ionized calcium, protein-bound calcium and
complexed calcium contribute to charge balance in the serum.
The same rationale also applies to serum magnesium.
The difficulty in establishing the precise charge contributions
of sulfate and organic acid anions arises because clinical
laboratories do not measure these serum constituents on a
routine basis. The normal fasting serum sulfate level is 0.297
0.038 mmollliter (mean SD); thus sulfate contributes about 0.6
mEq/liter to total serum anions [2]. Van Slyke estimated that
organic acids contribute 6 mEq/liter to serum unmeasured
anions [3], whereas Van Leeuwen estimated this contribution to
be only 3.2 mEq/liter [4]. Van Slyke, however, did not estimate
the contribution of specific organic acid anions, and Van
Leeuwen considered only lactate. Recent information indicates
that at least 29 acid anions are detectable in plasma [5]. In
normal individuals the aggregate contribution to the serum
anions by lactate, pyruvate, acetoacetate, 3-hydroxybutyrate,
and citrate is approximately 1.8 to 2.6 mEq/liter [6].
Although the concentration of serum phosphate is readily
obtainable through the clinical laboratory, it is not a simple
matter to derive the charge of phosphate; the latter is a function
not only of concentration but also of the serum pH. Serum
phosphorus concentration in mgldl is converted to mmol/liter
by multiplying by 10 and dividing by 31, the atomic weight of
phosphorus. The value is converted to mEq/liter of inorganic
phosphate by taking into account the pKa2' of the phosphate
buffer system, which is 6.8. Two negative charges are exposed
per molecule of basic phosphate, HPO4, and one per molecule
of acid phosphate, H2P04. The negligible amounts of H3P04
and P04 in serum are ignored. The ratio of H2P04 to H2P04
equals l0h1_68). At a pH of 7.4, this ratio is approximately 4 to
1. Thus four-fifths or 80% of the phosphate contributes two
negative charges as HP04, and one-fifth or 20% contributes
one charge as H2P04. Thus, the charge contribution of phos-
phate in mEq/liter at pH 7.4 is obtained by multiplying the
molar concentration of phsophate by the sum of 0.8 times 2 and
0.2 times 1, that is, 1.8.
Example: Given a serum phosphorus of 4.0 mg/dl and a
serum pH of 7.40:
4.0 mg/dl 3.1 = 1.29 mrnol/liter
[HPO4=]/[H2P04] = 1O(78) 4
% [HPO] = 100 x 4 (4 + 1) = 80%
[HPO4] = 0.80 x 1.29 = 1.03 mmol/liter
Therefore: [HP04] = 1.03 mmol/liter x 2 mEq/mmol =
2.06 mEq/liter[H2P04] = 0.26 mmol/liter x 1 mEq/mmol =
0.26 mEq/liter
[HPO4=I + [H2P04] = 2.06 + 0.26 = 2.32 mEq/liter
Simply: [H2P04] + [H2P04J = 1.8 mEq/mmol
x 1.29 mmol/liter = 2.32 mEq/liter
Normal serum proteins are polyanions. Although their net
contribution to overall charge balance is difficult to assess
exactly, a normal mixture of serum proteins contributes 1.8 to
2.4 mEq/liter per gram of protein at pH 7.40. This charge
reflects a number of variables: the type of protein, the concen-
tration of protein, and serum pH. The number of negative
charges on a protein molecule may not correspond to the
contribution to charge balance in the serum because a cation on
the protein surface may bind to more or less than one negative
charge. Thus Van Leeuwen uses the term net cation equivalen-
cy (NCE) [4], and Van Slyke speaks of the base bound by
protein (BBP) [31 to represent the charge balance contribution
of protein.
Albumin contributes about 2.0 to 2.8 mEq/liter for each g/dl
in human serum, and globulin provides approximately 1.3 to 1.9
mEq/liter for each g/dl. Van Leeuwen found a negligible NCE
for gamma globulin and assumed that the alpha and beta
fractions contributed all of the NCE attributable to the globulin
[4]. Changes in pH affect the NCE by either associating (lower
pH) or dissociating (higher pH) protons from reactive chemical
groups and by altering the tertiary structure of the protein. Both
Van Slyke and Van Lecuwen reported an increase in BBP or
NCE of 0.10 mEq/liter per g/dl of protein for each increment in
pH of 0.10 units [3, 4]. A summary of the contributions of total
protein, albumin, and globulin to normal serum charge balance
is expressed in the following equations:
Van Slyke BBP = 1.04 x [protein, g/dl] x (pH — 5.08)
Van Leeuwen NCE = 1.03 x [protein, gIdl] x (pH — 5.66)
From the foregoing, it obviously is impractical to employ a
formula for serum charge balance that demands measurement
of all the constituents. In fact, the utility and appeal of the anion
gap concept stems partially from the ease with which this
complex multivariable equation reliably can be simplified to one
in which only readily available determinations are utilized:
serum sodium, chloride, and bicarbonate (actually total carbon
dioxide content) concentrations. In this simplification, potassi-
um, calcium, and magnesium are considered unmeasured cat-
ions (UC) and phosphate, sulfate, protein, and organic acids are
considered unmeasured anions (UA). This simplification thus
requires neither measurement of all the serum constituents nor
calculation of their charge contribution. Nonetheless, the sim-
plification still accurately describes the electrically neutral state
of the serum:
Na + UC HC03 + Cl- + UA, or
Na — HC03 — Cl = UA — UC = anion gap.
Henceforth in this essay I will define the anion gap as follows:
anion gap = [Na — (Cl + TCO2)]
Applying normal values for serum concentrations of sodium,
chloride, and bicarbonate yields a predicted normal anion gap
of 10 to 12 mEq/liter. Indeed, most published studies report a
mean value of 12 mEq/liter and a range of 8 to 16 mEq/liter
encompassing two standard deviations [6—8]. Such data are
based on flame photometric determinations of sodium and on
measurements of Autoanalyzer chloride and total carbon diox-
ide. Newer laboratory methods may result in slightly lower
normal values, but the principles discussed here still apply.
From the equation that I just elucidated, which defines the
anion gap, it is clear that a decrease or increase in the gap could
result from a number of perturbations. Irrespective of such
perturbations, however, electroneutrality is always maintained.
Disorders associated with an altered anion gap 475
For example, increases in both the chloride and unmeasured
cation concentrations decrease the anion gap, as can occur in
patients with hyperproteinemia secondary to multiple myelo-
ma. Increases in the anion gap are more common than are
decreases. Increases can result from an increase in organic
anions and a concomitant decrease in the serum bicarbonate
concentration, as in lactic acidosis. Although an increase in
unmeasured anions theoretically could result from an increased
negative charge contribution by phosphate, protein, sulfate, or
organic anions, for practical purposes only increases in organic
anions account for large increases in the anion gap.
In the following sections, I will discuss first the acidemic and
alkalemic states accompanied by an increased anion gap and the
observed constituents of a large gap. Then I will consider the
disorders accompanied by a decreased anion gap.
Increased anion gap in acidemic states
Historically, the recognition that an overproduction of organ-
ic acids increases the anion gap but that an isolated loss of
bicarbonate does not has been responsible for the popularity of
the anion gap concept. Thus, assessment of the gap is helpful in
differentiating metabolic acidosis into its two major types:
acidosis with an increased anion gap, in most of which organic
acids cause the acidosis, and acidosis with a normal anion gap
(hyperchloremic), in which loss of bicarbonate occurs with a
concomitant increase in serum chloride.
Patient 1 is an instructive example of the diagnostic utility of
the anion gap. He had profound hypobicarbonatemia and an
increased anion gap almost certainly caused by an increased
production of organic acids (Table 1). Why does an increase in
organic acids result in an increased anion gap, as calculated
from the serum sodium, chloride, and bicarbonate concentra-
tions? The organic acids generated are buffered in substantial
part by extracellular bicarbonate with the resultant consump-
tion of bicarbonate and the appearance of an unmeasured
organic anion (0A), in accordance with the following
equation:
HOA (organic acid) + Na + HC03
Na 0A + F120 + CO2.
Thus, in this setting, the increase in the anion gap results
from the buffering of generated organic acids. However, it is not
true that an increase in endogenously generated organic acids
and the subsequent buffering of these acids always leads to an
increase in anion gap. In diabetic ketoacidosis, for example, the
end result of increased ketoacid production can be either
hyperchioremic acidosis or acidosis with an increased anion gap
[9]. The explanation for this variability is not straighforward.
Ketoacids are excreted in the urine at very low serum levels. If
the patient maintains an adequate salt intake and preserves
normal or nearly normal extracellular fluid volume, renal perfu-
sion, and glomerular filtration rate, ketoanions may be excreted
nearly as fast as they are generated. Under these circum-
stances, chloride is retained by the kidney in place of ketones, a
rise in the serum chloride balances the fall in the serum
bicarbonate concentration, and the serum anion gap remains
normal. If extracellular fluid volume is not preserved, however,
as is usually the case, renal function declines and the excretion
of ketoanions is retarded. An acidosis with an increased anion
gap results. In other varieties of organic acidosis, less potential
Table 3. Characteristics of anion gap acidosisa
Level of
anion gap Systemic
Disorder
Organic acid
responsible
(% of f AG)
mEqiliter pH
Range
Mean
Non-toxin related
Diabetic ketoacidosis
[9 751b
/3-OH butyric acid
Acetoacetic acid
(26%—143%)
18—44 6.95—7.36
33 7.17
18% > 35 0% > 7.40
Lactic acidosis [54, Lactic acid 18—67 6.75—7.54
55, 76, 771 Pyruvic acid 32 7.14 0.22
30% > 35 20% > 7.40
Renal failure, acute' SO4, PU4, a 16—29 —
[50] variety of
organic acids
(%?)
22 5 —
0% > 35 —
Renal failure, 17—23 7.19—7.42
chronic [78, 79] 7.35 0.06
Hyperglycemic, Unknown 18—36 6.81—7.43
hyperosmolar 29 7.30 0.17
nonketotic coma 10% > 35 25% > 7.40
[33]
Rhabdomyolysis" Unknown 16—55 6.69—7.90
[50] 27 7.33 0.26
16% > 35 42% > 7.40
Heat stroke without Lactic acid 21—27 7.26—7.44
hypotension (17%—68%) 23 2 7.34 0.12
Classic" [51, 521 0% > 35 33% > 7.40
Heat stroke without Lactic acid and 18—34 —
hypotension others 24 6 —
Exertional [80] 0% > 35 —
Toxin related
Alcohol [6, 35, 36, Ketoacids 19—37 6.96—7.76
47—49] BHB > AcAc
Lactic acid
(19%—98%)
26 6 7.28 0.18
8% > 35 56% > 7.40
12% < 20
Methanol" [31, 38, Formic acid 17—65 6.7—7.58
40, 81] Lactic acid
(%?)
32 7.17 0.22
35%>35 17%>7.40
Ethylene glycol [32, Lactic acid 11—58 6.72—7.37
40, 45, 46] Glycolic acid
Oxalic acid
37 11 6.98 0.2
42% > 35 0% > 7.40
Salicylates [29, 30, Variety of organic 10—34 7.32—7.61
37] acids (% ?) 0% > 35 7.43 0.1
60% < 20 50%> 7.40
Toluene [26—28]" Unknown 17—39 6.88—7.35
14%> 35 7.13 0.15
32% < 20 0% > 7.40
a Data utilized available on request to author.
Numbers in brackets refer to references.
"Subjects included only if anion gap > 16 mEq/liter.
d BHB refers to /3-OH butyric acid; AcAc refers to acetoacetic acid.
exists for the development of hyperchloremic acidosis because
the other organic acids have higher renal thresholds even in the
presence of normal renal function [10].
Another issue exemplified by the first patient is the identifica-
tion of the specific cause of the increased anion gap and
acidemia. Table 3 lists the disorders associated with increased
anion gaps. Among these disorders, renal failure is unique in
that a decrease in renal function rather than an increase in
organic acid production accounts for the increase in the anion
gap. In addition to the more common disorders listed in Table 3,
occasional cases of acidosis with an increased anion gap have
been reported after intoxication with iron [11, 12], hydrogen
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sulfide (by inhalation) [13], nalidixic acid [14], papaverine [15],
paraldehyde [16—211, strychnine [22], isoniazid [23, 24], and
with outdated tetracycline [25]. In keeping with the diminished
therapeutic use of paraldehyde, no cases of intoxication with
this agent have been reported in more than a decade.
The differential diagnosis of acidosis with an increased anion
gap is extensive, and one must utilize the history, physical
examination, and supporting laboratory data to identify the
specific cause when it is not apparent. As in the first patient, the
history provides the most critical information. Patients should
be questioned specifically about a history of diabetes, renal
disease, and alcohol or other drug ingestions. For example,
alcoholic ketoacidosis, one of the most common causes of this
type of metabolic acidosis, most often is diagnosed from the
history. Patients with this condition typically abuse alcohol
chronically and admit recent heavy alcohol consumption, usual-
ly accompanied by inadequate caloric intake and vomiting.
The physical examination provides important information
regarding tissue perfusion, a characteristic exhaled odor, and
mental status. The presence of acidosis with an increased anion
gap in a patient in shock most often is due to lactic acidosis. In
less dramatic clinical settings, however, the diagnosis of lactic
acidosis is verifiable less often. In our study, lactic acidosis was
confirmed biochemically in only 43% of the patients in whom it
was suspected on clinical grounds [61. As in this patient with
ethylene glycol intoxication, lactic acidosis can be superim-
posed on another disorder.
In a patient with unexplained metabolic acidosis with an
increased anion gap, the degree to which the anion gap is
elevated can be helpful in identifying the cause. Among the
disorders listed in Table 3, patients who have sniffed solvents
[26—28] or who are intoxicated with salicylates [29, 30] com-
monly have anion gaps of 17 to 19 mEq/liter. Patients with the
other disorders listed usually have anion gaps between 20 and
30 mEq/liter. Patients with anion gaps greater than 35 mEq/Iiter
usually have ethylene glycol or methanol intoxication or lactic
acidosis. Rarely, patients with methanol [31] or ethylene glycol
intoxication [32], hyperglycemic hyperosmolar coma [33], and
lactic acidosis [34] can have anion gaps greater than 50 mEq/
liter. Therefore, intoxication with methanol or ethylene glycol
was considered in this patient on the basis of the markedly
increased anion gap alone. Severe acidemia (pH < 7.00) occurs
most commonly in diabetic ketoacidosis, lactic acidosis, and
methanol or ethylene glycol intoxication. Hyperglycemia sug-
gests diabetic ketoacidosis or hyperglycemic hyperosmolar
coma, although modestly elevated serum glucose levels, <250
mg/dl, can occur in alcoholic ketoacidosis. Hyperglycemia and
glycosuria also can occur in salicylate intoxication [301. Con-
versely, hypoglycemia should suggest alcoholic ketoacidosis
because serum glucose levels are lower than 50 mg/dl in about
13% of patients with this disorder [35, 36]. Ketonuria occurs
almost invariably in diabetic ketoacidosis, commonly in alco-
holic ketoacidosis, and in approximately 25% of patients with
salicylate intoxication [37]. Ketonuria has been reported in
patients with methanol intoxication [38], but these patients
were also consuming ethanol and may have had alcoholic
acidosis as well. Assessment of renal function is valuable,
although it is unusual for metabolic acidosis with an increased
anion gap to be the major manifestation of either acute or
chronic renal failure. In patients with ethylene glycol intoxica-
tion, the urine sediment can contain many calcium oxalate
crystals. Testing blood and urine for the toxins listed in Table 3
may be diagnostic when ingestion of a toxin is suspected or
when there is no other apparent cause for acidosis with an
increased anion gap.
Calculation of the osmolal gap may be helpful, particularly if
methanol and ethylene glycol levels cannot be determined
rapidly. The utility of the osmolal gap is illustrated by Patient 1.
The osmolal gap is defined as the difference between the
measured and the calculated plasma osmolality. The plasma
osmolality can be measured quickly in most clinical laboratories
and also can be calculated by the application of one of a variety
of equations developed for this purpose [39]. A sophisticated
version recently has been used in studies of methanol and
ethylene glycol intoxication [40]:
osM = [1.86 Na(mEq/liter) + serum glucose (mg/dl)/l8
+ BUN (mg/dl)/2.8 + ETOH (mg/dl)/4.6] 0.93
The sodium is multiplied by 1.86 to account for the effect of
ionic activity; the serum glucose, urea, and ethanol are divided
by their molecular weight to convert the units to mOsm/kg H20.
Division by 0.93 simply corrects for the percentage of plasma
water. In subjects in whom methanol or ethylene glycol intoxi-
cation is suspected, ethanol should be included in the calcula-
tion because it is the most commonly encountered exogenous
substance with osmolar activity sufficient to influence the
results. A discrepancy of 10 mOsm or more between measured
and calculated osmolality, as occurred in Patient 1, suggests the
presence of an osmotically active substance in the plasma that
is not measured and thus not included in the calculation. Such
an elevation of the osmolar gap occurs in methanol and ethylene
glycol intoxication, chronic renal failure [41], shock with lactic
acidosis [42], and diabetic ketoacidosis [40].
Jacobsen et a! found that the osmolal gap ranged from 37 to
125 mOsm/kg H20 in methanol intoxication and from 21 to 49
mOsm/kg H20 in ethylene glycol intoxication [401. In methanol
and ethylene glycol intoxication, there is a significant correla-
tion between the serum level of the intoxicant and the osmolal
gap [40]. An osmolal gap also is present when the percentage of
plasma water is reduced, as in hyperlipemic states. Acetonemia
and reduction of plasma water can account for the osmolal gap
that sometimes occurs in diabetic ketoacidosis [40]. The nature
of the unmeasured osmotically active substances found in
chronic renal failure and in lactic acidosis is not known. An
increased osmolal gap in the absence of severe diabetic ketoaci-
dosis, chronic renal failure, or lactic acidosis is suggestive of
methanol or ethylene glycol intoxication and, as in Patient 1,
can provide additional support for the diagnosis.
Increased anion gap in alkalemic states
As the second patient under discussion today demonstrates,
an increased anion gap can occur in alkalemic as well as in
acidemic states, For example, alkalemia can exist despite an
increase in organic acid production if a concomitant and over-
riding metabolic or respiratory alkalosis is present. Moreover,
alkalemia itself can induce an increase in organic acid produc-
tion [43]. In addition, an increased anion gap and alkalemia can
coexist even in the absence of an increase in organic acid
production; first, as mentioned earlier, alkalemia tends to
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increase the net negative charge of serum proteins and second,
certain exogenously administered anions can, via metabolism
or effects on renal function, generate metabolic alkalosis and,
by partial persistence in the circulation, elevate the anion gap. I
will elaborate on these points in a moment. In our study of
patients with an increased anion gap, 10 of the 42 subjects were
alkalemic, and 9 had a normal serum pH [6].
Admittedly, increased organic acid production, as in diabetic
ketoacidosis, lactic acidosis, and intoxication with ethylene
glycol or methanol, typically is associated with acidemia, but
even in these disorders exceptions do occur [44—46]. Patients
with certain other disorders associated with an increased anion
gap quite frequently are alkalemic. For example, alkalemia
occurs in as many as 50% of patients with either alcoholic
ketoacidosis [6, 35, 36, 47—491 or salicylate intoxication [30].
Similarly, in one study 42% of 52 patients with rhabdomyolysis
and an increased anion gap were alkalemic [501. Four of 7
patients with classic heat stroke and an increased anion gap in
the absence of hypotension had systemic pH values greater
than 7.39 [51, 52].
Alkalemia in alcoholic ketoacidosis, salicylate intoxication,
rhabdomyolysis, and classic heat stroke usually is accounted
for by the coexistence of either respiratory or metabolic alkalo-
sis or both, present to a degree sufficient to counteract the
acidifying effect of organic acid overproduction. This mixed
acid-base disturbance is illustrated well by the second patient.
He had respiratory alkalosis with a PaCO2 of 16 mm Hg.
Respiratory alkalosis frequently occurs in patients, such as the
one under discussion, who are undergoing alcohol withdrawal.
He also had hyperbicarbonatemia and thus metabolic alkalosis.
Metabolic alkalosis is a frequent occurrence under these cir-
cumstances because profuse vomiting is often a prominent
feature of the clinical picture [49]. Quite commonly, again as in
this patient, the increase in the anion gap is the only evidence
signifying the presence of metabolic acidosis. As a corollary,
the degree of hyperbicarbonatemia would be even more marked
were it not for the coexisting organic acidosis. Indeed, the anion
gap can be used to estimate the "potential" bicarbonate con-
centration in such cases of mixed metabolic acidosis and
alkalosis; if one adds the increment in the anion gap to the
actual serum bicarbonate concentration, a measure of the true
extent of the metabolic alkalosis can be obtained. In Patient 2
for example, this calculation yields a "potential" bicarbonate
concentration of 57 mEq/liter. One can think of this value as the
level of serum bicarbonate concentration that would have been
present had the newly formed organic acids not titrated away a
portion of the bicarbonate. During recovery, however, the
serum bicarbonate concentration rarely if ever rises to the
anticipated level. As in Patient 2, repair of the metabolic
acidosis usually is accompanied by only a modest rise in the
serum bicarbonate concentration. The reason for this apparent
discrepancy is not clear. However, the attenuated increment in
serum bicarbonate may reflect in part the bicarbonaturia that
accompanies the restoration of extracellular volume and the
provision of an adequate amount of chloride. The urine pH of
7.5 in this patient is consistent with this phenomenon.
The interpretation of an increased anion gap in patients with
alkalemia is complicated because alkalemia per se can affect the
anion gap. Alkalemia can increase both organic acid generation
and the contribution of protein negative charge to the anion gap.
7.35 7.40 7.45 7.50 7.55 7.60
Plasma pH
Fig. 2. Relationship between plasma anion gap and plasma pH during
chronic, diuretic-induced metabolic alkalosis in dogs. Open symbols
denote values obtained during control period; closed symbols denote
values obtained during metabolic alkalosis period. Equations for least-
squares regression lines are shown in respective panels; value for slope
of each line was significantly different from zero (P > 0.01). (From Ref.
57.)
In acute respiratory alkalosis, lactic acid production can in-
crease modestly and elevate plasma lactate by 2 to 3 mEq/liter.
The increase in lactic acid production appears to result from an
increased activity of phosphofructokinase which, in turn, en-
hances glycolysis via the Embden-Meyerhof pathway, and
increases the conversion of glucose to lactate [43].
The effect of metabolic alkalosis on organic acid production
has not been fully evaluated. Sodium bicarbonate administra-
tion does increase lactic acid production in experimental lactic
acidosis [531. Similarly, 2 patients with tumor-related lactic
acidosis treated with sodium bicarbonate reportedly had in-
creased lactic acid production following such therapy [54, 55].
Finally, Hood et al demonstrated that bicarbonate administra-
tion increases ketoacid excretion during starvation in obese
human subjects [56]. The authors did not, however, determine
whether the increase in ketoacid excretion resulted from an
increase in ketoacid production or from decreased utilization.
The elevated levels of organic acid anions evident in Patient 2
might reflect the influence of alkalemia on organic acid
production.
In addition to the putative stimulating effect of bicarbonate
administration and alkalemia on organic acid production, alka-
lemia increases unmeasured anion concentration increasing the
net negative charge on serum proteins. Two interrelated factors
are responsible. First, alkalemic states often are associated with
a reduction in extracellular fluid volume, hemoconcentration,
and a rise in the serum protein concentration. In Patient 2, for
example, serum protein concentration rose from 6.3 g/dl to 8.7
gldl. Second, proteins surrender protons when titrated in an
alkaline direction, thereby uncovering additional negative
charges.
The relationship between anion gap and pH during one study
of experimental metabolic alkalosis is illustrated in Figure 2
[57]. The magnitude of the increment in anion gap with respect
to the degree of alkalemia may well reflect both increased acid
production and the effect of alkalemia on protein charge. The
only organic anion measured in this study was lactate, which
increased slightly.
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Utilizing Van Leeuwen's formula [41, one would anticipate
that alkaline titration alone would have increased the anion gap
by 2.3 mEq/liter in Patient 2, whose pH rose from 7.40 to 7.76.
Adding the effects of increased serum protein concentration,
one can account for an increment in the anion gap of 7.5
mEq/liter in this patient. The observed increment of 23 mEq/
liter therefore cannot be ascribed solely to the effects of
alkalemia and must imply increased production of organic
acids.
Adding to the complexity of interpreting anion gap values in
subjects with alkalemia is the recognition that many alkalemic
patients have normal or low anion gap values and yet have no
evidence of disorders known to be associated with low anion
gaps [58—61]. This finding indicates that much remains to be
understood about the effect of alkalemia on charge contribution
and organic acid production.
Special comment should be made about circumstances in
which the anion responsible for elevating the anion gap is itself
responsible for the generation of a metabolic alkalosis and
alkalemia. When certain organic acid anions (for example,
lactate, citrate, acetate) are metabolized by tissues, hydrogen
ions are consumed, and bicarbonate ions are generated. The
metabolic events involved are summarized in the following
equations:
(I) H20 — H + 0H
(2) C3H503 (lactate) + H + 302 — 3H20 + 3C02
(3) OH + CO2 —p HC03
Thus:
(4) C3H503 + 302— 2H20 + 2C02 + HC03
It is evident that oxidation of lactate or any other organic
anion generates an equivalent amount of bicarbonate. During
brisk administration of these acid anions (usually with sodium
or potassium), a minimally increased anion gap and hyperbicar-
bonatemia can occur before all the exogenous anion is metabo-
lized completely. Following full metabolism, of course, the
anion gap returns to normal. This sequence can occur with the
administration of lactate, acetate, or citrate, particularly in the
setting of decreased renal function [62]. A similar sequence can
occur during recovery from an organic acid acidosis, especially
lactic acidosis, if exogenous bicarbonate has been
administered.
Under some circumstances, the administration of nonmeta-
bolizable salts of organic anions also can result in an increased
anion gap and alkalemia. The administration of carbenicillin
[63, 64] and high-dose penicillin [65] are possible examples;
although alkalemia is well known as a potential complication of
using these agents, little information is available about the anion
gap in these circumstances. Sodium-deprived rats given car-
benicillin do develop metabolic alkalosis associated with an
increased anion gap. These effects are accompanied by an initial
brisk diuresis with a marked increase in urinary potassium and
ammonium excretion [66].
It is clear from the foregoing that a wide variety of pathoge-
netic processes can affect the anion gap in alkalemic states: (1)
the coexistence of a metabolic acidosis with an increased anion
gap and either a metabolic alkalosis, a respiratory alkalosis, or
both; (2) an alkalemia-induced increase in organic acid produc-
tion; (3) an increase in protein negative charges that is due to a
Table 4. Relationship between level of anion gap and biochemical
diagnoses in 51 patients without renal failurea
Biochemically confirmed
Anion gap
mEqiliter
Number of
patients
organic acidosis
Number Percentage
17—19 7 2 29
20—24 20 13 65
25—29 15 12 80
30—45 9 9 100
Total 51 36 71
a Adapted from Ref. 6.
combination of alkaline titration of protein buffer groups and
hyperproteinemia consequent to volume depletion; and (4)
occasionally, the generation of metabolic alkalosis via the
effects of certain anions on metabolism or on renal tubular
function.
Accounting for the increased anion gap
I now would like to turn to the question, can one account for
increments in the anion gap by explicit changes in the various
serum constitutents that have been discussed? The answer is,
not nearly as often as one might imagine. For example, when
the anion gap is 17 to 19 mEqlliter, the increment seldom is due
to an accumulation of common, identifiable organic acid anions.
In our study, only 29% of patients with anion gaps in this range
had biochemically confirmed organic acidosis (Table 4) [6]. In
many instances, anion gaps in this range reflect alterations in
unmeasured cations, proteins, or phosphate.
By contrast, when the anion gap is greater than 30 mEq/liter,
an increase in one of the commonly occurring organic acids
usually is responsible. Indeed, in our study, an identifiable
organic acid anion was found in all patients with such elevations
in the anion gap (Table 4). Even under these circumstances,
however, the increment in the anion gap often exceeds the
measured concentration of organic acid anions. For example, in
the first 2 patients under discussion today, the measured levels
of organic acid anions respectively accounted for only 25% and
39% of the increment in anion gap observed. A review of 109
patients in whom measurements of organic acid anions were
carried out indicates that increases in organic acid levels
accounted for 13% to 200% of the elevations in anion gap [6].
In some instances, the failure of organic acids to fully account
for the increase in anion gap almost certainly is due to a failure
in identifying some or all of the responsible organic acids. In
Patient 1 for example, if glycolic acid, the major malefactor in
experimental ethylene glycol intoxication [67] had been mea-
sured, a more complete accounting of the increase in anion gap
might have been possible. In Patient 2, small amounts of several
organic acids were demonstrated, but gas chromatographic and
mass spectrophotometric techniques were required to do so.
This finding demonstrates the technical difficulty encountered
when one attempts to identify the majority of plasma organic
acids, some of which may increase significantly in metabolic
disorders, Indeed, in many disorders, the offending organic acid
remains to be identified, as indicated in Table 3. Even in
reasonably well-understood disorders such as diabetic ketoaci-
dosis, however, the degree to which identifiable organic acids
Disorders associated with an altered anion gap 479
Table 5. Causes of a decreased anion gap
Increased unmeasured cation
IgG multiple myeloma
Increased calcium, magnesium, or potassium
Acute lithium intoxication
Polymyxin B administration
Decreased unmeasured anions
Hypoalbuminemia
Dilution
Nonrandom analytical error
Hypernatremia (severe)
Hyperviscosity
Bromide intoxication
Iodide ingestion
Hyperlipidemia
contribute to the observed increase in anion gap ranges widely
from 26% to 143% [6]. The possibility that alterations in serum
constituents other than organic acids contribute to the discrep-
ancy also must be considered. Changes in the charge contribu-
tion of potassium, calcium, phosphorus, and protein can ac-
count for as much as a 9 mEq/liter increase in the anion gap.
Frequently an unexplained discrepancy exists between the
increase in the anion gap and the measurable alterations in the
serum constituents. An extensive systematic study of patients
with increased anion gaps will be required to clarify this issue.
Decreased anion gap
Disorders marked by a decrease in the anion gap have
received less attention than have those associated with an
increase, because downward deviations occur less often, and
disorders associated with such changes are less acutely life
threatening. The third patient under discussion today had an
anion gap of 5 mEq/liter, a value distinctly below normal. Table
5 lists disorders known to cause a decreased anion gap. This
patient clearly had multiple myeloma. The decreased anion gap
in this disorder reflects an increase in unmeasured cations; this
increase is due to the increased serum concentration of cationic
IgG paraproteins [68]. Characteristically IgG paraproteins have
isoelectric points higher than 7.40 and therefore are positively
charged at normal serum pH. Some investigators speculate that
plasma electroneutrality is maintained by an increase in plasma
chloride concentration; there are no data confirming this asser-
tion, however. Alterations in sodium, bicarbonate, or other ions
may preserve charge balance. Nonetheless, a significant in-
verse relationship exists between the concentration of the IgG
paraproteins in the serum and the level of the anion gap. In
addition to the effect of IgG paraproteins, hypercalcemia and
hypoalbuminemia also can contribute to a low plasma anion gap
in patients with multiple myeloma. A decrease in anion gap also
has been reported in patients with asymptomatic plasma cell
dyscrasias who demonstrate a paraprotein "spike" [691 and in
patients with diffuse polyclonal hypergammaglobulinemia [701.
It is of interest that IgA paraproteins are not associated with a
low anion gap because they have isoelectric points slightly
below 7.40 and therefore are anionic at normal pH. Indeed, the
anion gap potentially could be increased with IgA myeloma, but
such an occurrence has not been reported.
Increased levels of certain endogenous cations, namely calci-
um, magnesium, or potassium, theoretically could decrease the
anion gap. But no common disorders typically increase all
three, and an increase in any one of magnitude sufficient to
decrease the anion gap appreciably would not be compatible
with life. Some reduction in the anion gap can result from the
administration of cationic drugs; this alteration has been report-
ed in patients with lithium intoxication and in patients receiving
the polycationic antibiotic polymyxin B [71.
A reduction in the concentration of one or more unmeasured
anions also would be expected to reduce the anion gap. Indeed,
hypoalbuminemia is probably the most common cause of a
decreased anion gap in hospitalized patients. Each gram-per-
deciliter reduction in the serum albumin concentration would be
expected to reduce the anion gap by approximately 2.5 mEq/
liter. This mechanism is the most likely explanation for the
decreased anion gap frequently observed in patients with ne-
phrotic syndrome and in patients with advanced liver disease
[7].
Some reduction in the anion gap can occur in hypoosmolar
states, presumably as a result of dilution [7]. This change is
most apparent in the syndrome of inappropriate secretion of
antidiuretic hormone (SIADH). My personal review of case
reports reveals that almost 25% of patients with SIADH have an
anion gap of less than 6 mEq/liter.
Whenever an abnormally low value for anion gap is obtained,
consideration should be given to the possibility of laboratory
error. Among the causes of nonrandom laboratory error leading
to artifactual reduction in the anion gap, hypernatremia and
hyperviscosity are the most important. When serum sodium
concentration exceeds 170 mEq/liter, certain flame photo-
meters yield artifactually low values. In the presence of valid
measurements for bicarbonate and chloride concentrations,
falsely low values for serum sodium result in erroneously low
levels for the calculated anion gap. Hyperviscosity also can lead
to falsely low values for serum sodium and, hence, anion gap
because the flame photometer apparatus may fail to aspirate an
aliquot of hyperviscous serum sufficient to yield a valid result.
An artifactually high value for serum chloride concentration
of course would also result in a correspondingly low anion gap.
Historically, patients with bromide intoxication frequently ex-
emplified this phenomenon. Because bromide reacts very
strongly with the reagents utilized to measure chloride by the
Autoanalyzer method, artifactually high values for serum chlo-
ride concentration were frequently seen in bromide-intoxicated
patients [71]. Indeed, this laboratory error may be sufficient not
only to lower the value for the anion gap but in some instances
to render it negative. Fortunately, bromide intoxication has
become much less common in the United States because
organic bromides have been removed from virtually all drugs.
The pharmaceuticals that do contain bromide have such small
amounts that bromism does not occur with usual usage.
Iodide, another halogen capable of accumulating in the
serum, also can cause an artifactual increase in serum chloride
concentration and hence a decrease in the calculated value for
anion gap [72]. Overestimation of serum chloride concentration
also can occur, albeit by a different mechanism, in the presence
of hyperlipidemia [73]; in this case, lipids scatter light in such a
way as to falsely elevate the concentration of chloride when
determined by the colorimetric method [73].
Accuracy in the assessment of the anion gap depends, of
course, on the accuracy of measurement of the three constitu-
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ent substances involved in its calculation. Random errors in
measurement of the sodium, chloride, or total carbon dioxide
content can invalidate the anion gap calculation by falsely
elevating or reducing the value. Indeed, modest deviations in
the anion gap from normal frequently may be the consequence
of such errors.
Questions and answers
DR. ARNOLD BERNS (Attending Nephrologist, Michael Reese
Hospital): Does intracellular metabolism break down at the
extremes of pH, say below 6.9 or above 7.7, with the result that
a variety of different products of intermediary metabolism are
produced? And do these products, in the aggregate, contribute
to the anion gap?
DR. GABOW: We investigated this question in a preliminary
manner using gas chromatographic-mass spectroscopic tech-
niques. If the situation you proposed existed, one would
anticipate finding a variety of organic acids at extremes of pH.
In fact we occasionally have seen an increase in unusual organic
acids (Patient 2), but this does not appear to relate to pH.
Additionally, if what you're suggesting actually happens, one
would expect that commonly measured organic acids such as
lactate, pyruvate, acetoacetate, and /3-OH butyrate would
account for a lower percentage of the increase in anion gap in
severe acidemia. In fact, it appears that in severe acidemia the
accountability may be higher. This question has not been well
addressed in severe alkalemia and deserves further
investigation.
DR. DAVID BUSHINSKY (Renal Section, Mitchell Hospital,
Chicago): Given that one can find an increased anion gap in
each of the four cardinal acid-base disorders, the determination
might be regarded as insensitive and nonspecific. In view of
this, is it worth even calculating the anion gap, or should one
concentrate on actual laboratory measurements such as pH,
potassium, and the like in analyzing the patient with an acid-
base disorder?
DR. GABOW: The anion gap is simply additional data. More-
over, it is iree" data, calculated from the serum electrolytes.
In settings of acidemia and hypobicarbonatemia, an elevated
anion gap directs one's thinking toward certain disorders. An
anion gap greater than 0.5 (HC03) + 16, or greater than 30
mEq/liter, almost always indicates an increase of a common
organic acid, and this information is helpful. An elevated anion
gap is also useful in diagnosing mixed acid-base disorders.
DR. JORDAN J. COHEN: You noted that occasionally patients
with diabetic ketoacidosis develop a hyperchloremia rather
than an increased anion gap. What is the relationship between
this spontaneous hyperchloremia and the hyperchloremia that
frequently occurs during treatment and recovery from diabetic
ketoacidosis?
DR. GABOW: There have been a variety of explanations for
the hyperchloremia and hypobicarbonatemia that occur during
recovery. The ketoanions represent a potential source of bicar-
bonate in that during their metabolism they generate bicarbon-
ate. Ketoanions, and thus potential bicarbonate ions, are lost in
the urine during the development of diabetic ketoacidosis.
Therefore, when keto acid production stops and metabolism of
ketoanions begins, total body bicarbonate cannot return to its
original level; the anion gap normalizes, hypobicarbonatemia
persists, and a hyperchloremic acidosis is observed. Some
support for this explanation comes from the observation that
hyperchloremic acidosis is more common in the aftermath of
diabetic ketoacidosis, in which excretion of potential bicarbon-
ate as ketoanions is substantial, than it is in the aftermath of
lactic acidosis, which is accompanied by less renal excretion of
the lactate anion and less loss of potential bicabronate. Another
possible explanation is that the distribution space of bicarbon-
ate is different than the distribution space of the ketoanions.
Therefore, the bicarbonate generated by metabolism is distrib-
uted in a larger space than are the ketoanions, and this leads to a
rise in the serum bicarbonate that is less than the fall in the
anion gap. The spontaneous hyperchloremic hypobicarbonate-
mia that sometimes occurs during the development of diabetic
ketoacidosis probably reflects the former sequence of events. If
the keto acid production is low grade and if volume status is
well maintained, the keto acids will be buffered and the serum
bicarbonate concentration will fall, but the ketoanions will be
excreted in the urine. Thus potential bicarbonate is lost, chlo-
ride is retained in its place, and a hyperchloremic hypobicar-
bonatemic state results.
DR. COHEN: I suppose there is yet another possibility,
namely that persistent hyperventilation and hypocapnia during
recovery from acidosis reduces renal bicarbonate reabsorption
and enhances chloride reabsorption. Do you agree?
DR. GABOW: Yes.
DR. SHELDON HIRSCH (Medical Resident, Michael Reese
Hospital): I have been taught that the decrement in plasma
bicarbonate should be roughly equal to the increment in the
anion gap in uncomplicated, anion-gap metabolic acidosis and
that one should be suspicious of a coexisting acid-base disorder
whenever this relationship is disturbed. Do you find this rule to
be clinically valid and useful?
DR. GABOW: This is a reasonable "rule of thumb." The anion
gap results from the buffering of organic acids by bicarbonate,
and therefore the increase in the anion gap should be related to
the decrease in bicarbonate. It is probably not an equivalent
relationship, however. First, other buffers are involved in
addition to bicarbonate. Second, the distribution spaces of
bicarbonate and the anion may not be the same. But if the drop
in bicarbonate and the increase in anion gap are markedly
discrepant, it seems reasonable to consider the possibility of
other, coexisting acid-base disorders.
DR. COHEN: You pointed out that there are a number of
circumstances in which the anion gap can be enormously
elevated, reaching levels of 40 to 50 mEq/liter or higher.
Obviously, if a reciprocal relationship exists between the incre-
ment in anion gap and the decrement in bicarbonate concentra-
tion, such very high values could not occur unless a preexisting
or coexisting metabolic alkalosis were present to provide suffi-
cient bicarbonate for buffering. Indeed, as in the second patient
presented today, there is often a clear history of an alkalosis-
producing process, such as vomiting. But sometimes significant
hypochloremia is present in association with metabolic acidosis
and there is no obvious explanation for it. Have you observed
such patients and, if so, how do you explain this phenomenon?
DR. GABOw: My impression is similar to yours: occasionally
no obvious cause for hypochloremia and metabolic alkalosis
can be identified. In addition, it appears that the serum bicar-
bonate concentration never rises as much as one would antici-
pate from the level of the anion gap. This may reflect volume
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expansion and bicarbonaturia with recovery, but I have no
explanation for the initial discrepancy.
DR. SERAFTNO GARELLA (Department of Medicine, Michael
Reese Hospital): A potential explanation for such a discrepancy
might be derived from results of mineral acid infusion studies. If
we assume that organic acids titrate bicarbonate in much the
same fashion and to the same degree as do mineral acids,
hypochloremia might result. If only approximately 40% of the
total acid load is buffered by extracellular bicarbonate, and if
most of the offending organic acid anions remain in the extracel-
lular space, the fall in bicarbonate in organic acidosis would be
much smaller than the rise in the anion gap, the discrepancy
being accounted for by hypochioremia. Indeed, such a possibili-
ty has been confirmed by studies in nephrectomized rats [741.
DR. GARY TOBACK (Renal Section, Mitchell Hospital): The
administration of sodium bicarbonate appears to exacerbate
lactic acidosis on occasion. If this observation is valid, how
should lactic acidosis be treated?
DR. GABOW: First and foremost, of course, the underlying
cause for the lactic acidosis must be addressed, if possible.
How to treat the acidemia per se is a difficult question. As I
discussed, both alkalemia and bicarbonate administration ap-
pear to increase keto acid and lactic acid production in experi-
mental and clinical settings. Arieff's data from an experimental
animal model of lactic acidosis suggest that survival is the same
in dogs treated with sodium chloride as in dogs treated with
sodium bicarbonate. There is, however, no well-established
alternative to bicarbonate for the therapy of severe, life-
threatening acidosis at this time.
DR. BERNS: Have you had any experience with dichloroace-
tate in the treatment of lactic acidosis?
DR. GABOW: No, I have not been involved in a clinical trial of
dichioroacetate. Dichloroacetate activates pyruvic dehydrogen-
ase and thereby promotes the oxidation of pyruvate in vitro.
Thus, it was hypothesized that this agent might lower lactate
levels in vivo. In fact, it appears to do so in animal models of
lactic acidosis as well as in clinical lactic acidosis. Its utility
and, indeed, its precise mechanism of action remains to be
demonstrated in a large prospective trial.
DR. CHARLES BENNETT (Medical Resident, Michael Reese
Hospital): You commented that patients with diabetic acidosis
and hypovolemia tend to have an elevated anion gap, whereas
those who are normovolemic manifest hyperchloremia. Could a
case be made that diabetic patients with hypovolemia and an
elevated anion gap might do better if treated with lactated
Ringer's solution rather than with sodium chloride? Such an
approach to volume repletion might minimize these patients'
tendency to develop hyperchloremic acidosis during therapy.
DR. GABow: Adrogue et al suggest that administration of
sodium chloride solutions might contribute to the development
of hyperchloremic acidosis by accelerating the loss of ketoan-
ions, that is, potential bicarbonate, in the urine. Whether the
transient hyperchloremic acidosis that can occur in this setting
contributes to the length of hospitalization or to morbidity is not
clear. This possibility must be balanced against the risks of
giving bicarbonate or its equivalent in the form of lactated
Ringer's solution. As discussed, sodium bicarbonate may in-
crease keto acid production. Perhaps that might prolong the
period of ketoacidosis. In addition, the administration of bicar-
bonate may result in a rebound metabolic alkalosis. Until this is
studied in a controlled fashion, it would be difficult to determine
which solution or fluid therapy is ideal.
DR. COHEN: You mentioned that patients with hyperglyce-
mic, nonketotic hyperosmolar coma occasionally have very
large anion gaps. Such patients usually develop little if any
overt acidosis. How do you explain these findings?
DR. GAB0w: By traditional teaching, we would conclude that
such patients had metabolic alkalosis and a metabolic acidosis
based on the anion gap and the calculated potential bicarbonate
concentration. It is not unreasonable to assume that these
patients in fact have metabolic alkalosis due to the large
osmotic diuresis with sodium chloride loss. These patients
certainly have volume contraction and large sodium chloride
defects. Other factors not yet defined may also be operative.
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